Stakeholders have the right to know whether the industry and patient representatives on the HTA Review reference committee objected to the declaration of interest, primarily because it invalidates the input of the people and organisations they claim to represent. …
It's in the name - a stakeholder with an interest has a 'stake', not a conflict
February 22, 2024 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
Australia can increase prices in response to pressure, as it did just 36 months ago for 950 medicines
December 2, 2025 - - Latest News -
CLINUVEL advances second therapy toward market with planned 2026 European filing
December 2, 2025 - - Australian Biotech -
Burnt-Out Australians rush to health appointments as year-end pressure peaks
December 2, 2025 - - Other Health -
First patient successfully dosed in TRP-8803 trial to treat binge eating disorder
December 2, 2025 - - Australian Biotech -
Immutep unveils strong Phase 2 data ahead of San Antonio breast cancer symposium
December 2, 2025 - - Australian Biotech -
New national push to close Australia’s cardiovascular data gap
December 2, 2025 - - Latest News -
US and UK strike landmark pharmaceutical deal, lifting prices
December 2, 2025 - - Latest News